Literature DB >> 9731236

The chaperone-like alpha-crystallin forms a complex only with the aggregation-prone molten globule state of alpha-lactalbumin.

K Rajaraman1, B Raman, T Ramakrishna, C M Rao.   

Abstract

The chaperone-like alpha-crystallin prevents aggregation of several proteins by interacting with their non-native states. Alpha-Lactalbumin adopts different non-native states under different experimental conditions. We have investigated the interaction of alpha-crystallin with three non-identical non-native states, using fluorescence, circular dichroism, and gel filtration chromatography. The compact molten globule state of apo-alpha-lactalbumin in tris buffer does not interact with alpha-crystallin. The expanded, flexible molten globule-like state of reduced apo-alpha-lactalbumin (formed at pH 7.2) also does not interact with alpha-crystallin. Only the aggregation-prone non-native state of reduced apo-alpha-lactalbumin formed at pH 6.0 interacts with alpha-crystallin to form a stable complex. The alpha-crystallin bound reduced apo-alpha-lactalbumin exhibits properties similar to those of a molten globule. Our results show that alpha-crystallin interacts only with the aggregation prone molten globule state of reduced apo-alpha-lactalbumin but not with the other non-aggregating molten globule states of the protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731236     DOI: 10.1006/bbrc.1998.9242

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  The molecular chaperone alpha-crystallin is in kinetic competition with aggregation to stabilize a monomeric molten-globule form of alpha-lactalbumin.

Authors:  R A Lindner; T M Treweek; J A Carver
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

2.  Unfolding and refolding of a quinone oxidoreductase: alpha-crystallin, a molecular chaperone, assists its reactivation.

Authors:  S Goenka; B Raman; T Ramakrishna; C M Rao
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

Review 3.  Alpha-crystallin-type heat shock proteins: socializing minichaperones in the context of a multichaperone network.

Authors:  Franz Narberhaus
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

4.  Structure and orientation of T4 lysozyme bound to the small heat shock protein alpha-crystallin.

Authors:  Derek P Claxton; Ping Zou; Hassane S Mchaourab
Journal:  J Mol Biol       Date:  2007-11-13       Impact factor: 5.469

5.  AlphaB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid beta-peptide and beta2-microglobulin.

Authors:  Bakthisaran Raman; Tadato Ban; Miyo Sakai; Saloni Y Pasta; Tangirala Ramakrishna; Hironobu Naiki; Yuji Goto; Ch Mohan Rao
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

6.  Conserved F84 and P86 residues in alphaB-crystallin are essential to effectively prevent the aggregation of substrate proteins.

Authors:  Puttur Santhoshkumar; K Krishna Sharma
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

7.  The molecular chaperone alpha-crystallin as an excipient in an insulin formulation.

Authors:  Tue Rasmussen; Ruedeeporn Tantipolphan; Marco van de Weert; Wim Jiskoot
Journal:  Pharm Res       Date:  2010-03-24       Impact factor: 4.200

Review 8.  Probing early events in ferrous cytochrome c folding with time-resolved natural and magnetic circular dichroism spectroscopies.

Authors:  Eefei Chen; Robert A Goldbeck; David S Kliger
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

9.  Changes in solvent accessibility of wild-type and deamidated βB2-crystallin following complex formation with αA-crystallin.

Authors:  Kirsten J Lampi; Cade B Fox; Larry L David
Journal:  Exp Eye Res       Date:  2012-09-12       Impact factor: 3.467

Review 10.  Biology of Inherited Cataracts and Opportunities for Treatment.

Authors:  Alan Shiels; J Fielding Hejtmancik
Journal:  Annu Rev Vis Sci       Date:  2019-09-15       Impact factor: 6.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.